Aramark reported strong fourth-quarter earnings, exceeding analysts’ expectations. The company also announced a significant share repurchase program and raised its price target, signaling optimism for future growth. Analyst Jasper Bibb maintains a Buy rating on the stock.
Results for: Aramark
US stock markets ended the day with mixed results, with the Nasdaq falling slightly while the Dow and S&P 500 saw gains. Aramark announced strong fourth-quarter financial results and a share buyback program, driving its stock price up. Other notable movers included CERO Therapeutics and Canaan Inc., which surged due to positive news, while 1847 Holdings, RAPT Therapeutics, and Sapiens International Corporation saw significant declines.
Aramark (ARMK) stock is trading higher after the company reported strong fourth-quarter earnings, including revenue growth driven by strong volume across both segments. The company also raised its quarterly dividend and announced a new share repurchase program. Aramark expects continued growth in the coming year, with organic revenue growth projected to be between 7.5% and 9.5%.
Aramark (ARMK) is set to release its fourth-quarter earnings on Monday, November 11th. Analysts expect a dip in earnings compared to last year, but investors are also looking at the company’s dividend yield. This article explores how much you would need to invest in Aramark stock to generate monthly dividend income of $500 or $100, while also examining the factors that can influence the dividend yield and current stock price action.
French food services giant Sodexo is reportedly in talks to acquire its U.S. rival Aramark, sending Aramark’s stock soaring over 10% in after-hours trading. The potential deal, however, faces antitrust scrutiny and would require Sodexo to secure significant funding.